WorldPharma giants push for tariff clarity as ambiguity threatens EU-U.S. deal Last updated: July 29, 2025 3:18 pm TARESH SINGH Share 0 Min Read SHARE The pharma sector remains under a U.S. Section 232 investigation, with the outcome due by August.Related Concert by Putin ally Gergiev cancelled in Italy Ferrari shares slump 12% in biggest drop since 2016 listing China’s July manufacturing activity contracts more than expected — declines for fourth-straight month Qualcomm beats on earnings, highlights growth in Meta smartglasses Divided Fed holds key interest rate steady, defying Trump’s demands for aggressive cuts Share This Article Facebook Pinterest Whatsapp Whatsapp LinkedIn Telegram Threads Copy Link Print Share Previous Article Sanjay Dutt’s first look from ‘The Raja Saab’ out Next Article How to properly water and care for your plants before leaving for a vacation Leave a Comment Leave a Comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment *Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Latest News Ishita Dutta shares health update from hospital bed with son Vaayu Entertainment July 31, 2025 ‘Rummy’ row: Maharashtra NCP minister Manikrao Kokate loses agriculture portfolio, given sports; accused of playing online game in legislative council Politics July 31, 2025 Election Commission finalises electoral college list ahead of upcoming vice-presidential election Education Politics July 31, 2025 Nadda slams opposition for walkout during Shah’s reply on Operation Sindoor; Kharge says protest was over insulting remark July 31, 2025 Google news feed
